Regulatory pathways for developing market vaccines

Expert Review of Vaccines

Volumn 2, Issue 5, 2003, Pages 599-601

  Milstien, Julie ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; ROTAVIRUS VACCINE; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; SMALLPOX VACCINE; UNCLASSIFIED DRUG; VACCINE;

ANTHRAX; BIOLOGICAL WARFARE; CLINICAL TRIAL; DRUG MARKETING; DRUG RESEARCH; EDITORIAL; ETHICS; FOOD AND DRUG ADMINISTRATION; HUMAN; LICENSING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; RISK BENEFIT ANALYSIS; SEVERE ACUTE RESPIRATORY SYNDROME; SMALLPOX; VACCINE PRODUCTION; VIRUS PNEUMONIA;

EID: 0142058103     PISSN: 14760584     EISSN: None     Source Type: Journal    
DOI: 10.1586/14760584.2.5.599     Document Type: Editorial

References (0)